Interestingly, when only stage 1 patients were considered for combined TLR1-10 analysis (Figure 3B, n=449 for NSCLC; Figure 3D, n=346 for ADC), the HR were further decreased (NSCLC, HR = 0.36, P =1.9 × 10−9; ADC, HR =0.37, P = 3.8 × 10−6). This evidence concerns the gene TLR1 and non-small cell lung carcinoma.